Methods for synthesis of the tricyclic prostaglandin d2 metabolite methyl ester
US-2026062381-A1 · Mar 5, 2026 · US
C-3 substituted bicyclooctane based HIV protease inhibitors
US9309213B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9309213-B2 |
| Application number | US-201214131849-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 11, 2012 |
| Priority date | Jul 11, 2011 |
| Publication date | Apr 12, 2016 |
| Grant date | Apr 12, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
C3-functionalized-cyclopentanyltetrahydrofuranyl carbamates that inhibit HIV proteolytic enzymes and processes for preparing the compounds are described. Compositions comprising the disclosed compound and methods of using the compounds and/or compositions for treating patients infected with HIV are also described.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound having the formula or a pharmaceutically acceptable salt, isomer, mixture of isomers, crystalline form, non crystalline form, hydrate, or solvate thereof; wherein X 1 is C(O), S(O), S(O) 2 , HNS(O) 2 , HNC(O), or C(O)NH; R 1 and R 2 are in each instance independently selected from the group consisting of hydrogen, and a prodrug form…
Assignees
Inventors
Classifications
- C07D307/935Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9309213B2 cover?
- C3-functionalized-cyclopentanyltetrahydrofuranyl carbamates that inhibit HIV proteolytic enzymes and processes for preparing the compounds are described. Compositions comprising the disclosed compound and methods of using the compounds and/or compositions for treating patients infected with HIV are also described.
- Who is the assignee on this patent?
- Ghosh Arun K, Mitsuya Hiroaki, Chapsal Bruno D, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification C07D307/935. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).